Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

De Novo and Bi-allelic Pathogenic Variants in NARS1 Cause Neurodevelopmental Delay Due to Toxic Gain-of-Function and Partial Loss-of-Function Effects

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Leveraging both individual-level genetic data and GWAS summary statistics increases polygenic prediction

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Exome-Derived Adiponectin-Associated Variants Implicate Obesity and Lipid Biology

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Two cases of somatic STK11 mosaicism in Danish patients with Peutz-Jeghers syndrome

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Successful treatment with dupilumab of an adult with Netherton syndrome

    Publikation: Bidrag til tidsskriftLetterForskningpeer review

  3. Guideline: Udredning og opfølgning for arvelige polyposesyndromer

    Publikation: AndetAndet bidragFormidling

  4. Udredning og opfølgning af familiær aneurisme sygdom

    Publikation: AndetAndet bidragFormidling

  5. Revised Danish guidelines for the cancer surveillance of patients with Cowden Syndrome

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  • SYNAPS Study Group
Vis graf over relationer

Aminoacyl-tRNA synthetases (ARSs) are ubiquitous, ancient enzymes that charge amino acids to cognate tRNA molecules, the essential first step of protein translation. Here, we describe 32 individuals from 21 families, presenting with microcephaly, neurodevelopmental delay, seizures, peripheral neuropathy, and ataxia, with de novo heterozygous and bi-allelic mutations in asparaginyl-tRNA synthetase (NARS1). We demonstrate a reduction in NARS1 mRNA expression as well as in NARS1 enzyme levels and activity in both individual fibroblasts and induced neural progenitor cells (iNPCs). Molecular modeling of the recessive c.1633C>T (p.Arg545Cys) variant shows weaker spatial positioning and tRNA selectivity. We conclude that de novo and bi-allelic mutations in NARS1 are a significant cause of neurodevelopmental disease, where the mechanism for de novo variants could be toxic gain-of-function and for recessive variants, partial loss-of-function.

OriginalsprogEngelsk
TidsskriftAmerican Journal of Human Genetics
Vol/bind107
Udgave nummer2
Sider (fra-til)311-324
Antal sider14
ISSN0002-9297
DOI
StatusUdgivet - 6 aug. 2020

Bibliografisk note

Copyright © 2020. Published by Elsevier Inc.

ID: 61319109